OPTIMISE (hOme-based sleeP moniTor In Movement dISordErs)
Summary
Cervical dystonia and levodopa-induced dyskinesia (or LID) in Parkinson’s disease are two common movement. Our understanding of these conditions is still limited which led to very few treatment options for its motor symptoms. However, the non-motor symptoms are also common in dystonia and LID. One of these non-motor symptoms is the poor sleep quality. Dr. Davide Martino at the University of Calgary is leading a research study to gain a better understanding of the brain activity during the sleep (better known as the sleep architecture) and the quality of sleep in the people diagnosed with dystonia and LID. This study aims to gain a better understanding of this non-motor aspect of dystonia and LID.
This is an observational study. Complete participation in the study comprises a single visit followed by 7 nights of recording of your sleep at your home. The study duration depends on your schedule and availability.
As part of this study, we will ask you to undergo one clinical assessment involving physical examination and questionnaires about your mood, anxiety, and sleep quality.
Eligibility
Eligible ages: 18 to 75
Accepts healthy participants: Yes
Inclusion criteria:
To be eligible in the study, participants must:
1) be adults;
2) either have a diagnosis of cervical dystonia, or a diagnosis with Parkinson's disease and associated dyskinesia, or be neurologically healthy;
3) not be using any psychoactive medication or recreational substance.
4) not already carry other medical devices or implants that can be affected by the magnets contained in the Muse-EEG system.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Please contact directly Dr. Davide Martino (Principal Investigator)
Principal investigator:
Davide Martino
Clinical trial:
No
REB-ID:
REB25-0323